ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 275 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 2.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $290,777 | -100.0% | 12,141 | -73.7% | 0.00% | -60.0% |
| Q2 2022 | $651,011,000 | -60.3% | 46,171 | -31.7% | 0.01% | -50.0% |
| Q1 2022 | $1,638,289,000 | -14.5% | 67,642 | -17.6% | 0.01% | -9.1% |
| Q4 2021 | $1,916,615,000 | +27.0% | 82,082 | -9.6% | 0.01% | +10.0% |
| Q3 2021 | $1,508,852,000 | -33.5% | 90,840 | -2.3% | 0.01% | -33.3% |
| Q2 2021 | $2,267,270,000 | -5.0% | 92,959 | +0.5% | 0.02% | -11.8% |
| Q1 2021 | $2,385,881,000 | -19.0% | 92,476 | +67.8% | 0.02% | -34.6% |
| Q4 2020 | $2,945,539,000 | +216.8% | 55,098 | +144.4% | 0.03% | +160.0% |
| Q3 2020 | $929,858,000 | – | 22,542 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 28,439,114 | $590,396,000 | 3.89% |
| GREAT POINT PARTNERS LLC | 1,196,098 | $24,831,000 | 3.87% |
| EMORY UNIVERSITY | 196,601 | $4,081,000 | 2.67% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| NEXTHERA CAPITAL LP | 500,000 | $10,380,000 | 1.99% |
| Palo Alto Investors LP | 1,684,180 | $34,964,000 | 1.41% |
| Opus Point Partners Management, LLC | 20,828 | $432,000 | 1.03% |
| Opaleye Management Inc. | 195,000 | $4,048,000 | 1.03% |
| GARRISON BRADFORD & ASSOCIATES INC | 48,500 | $1,007,000 | 0.81% |